WO2023057818 - SYSTEMS AND METHODS FOR TREATING FLUID OVERLOAD
National phase entry:
Publication Number
WO/2023/057818
Publication Date
13.04.2023
International Application No.
PCT/IB2022/000577
International Filing Date
07.10.2022
Title **
[English]
SYSTEMS AND METHODS FOR TREATING FLUID OVERLOAD
[French]
SYSTÈMES ET PROCÉDÉS DE TRAITEMENT DE SURCHARGE DE FLUIDE
Applicants **
AQUAPASS LTD
14 Ha'ilan St.
P.O.B. 148
3065101 Or-Akiva, IL
Inventors
NITZAN, Yaacov
Tidhar 6
4636535 Hertzelia, IL
Priority Data
63/253,991
08.10.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2875 | |
| EPO | Filing, Examination | 16717 | |
| Japan | Filing | 595 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 8410 |
Total: 29172 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention generally relates to systems and methods for treating fluid overload in a patient by providing controlled stimulation of fluid transfer directly and non-invasively from an interstitial compartment of the patient through the skin of the patient.[French]
L'invention concerne de manière générale des systèmes et des procédés permettant de traiter une surcharge de fluide chez un patient par la fourniture d'une stimulation contrôlée de transfert de fluide directement et de manière non invasive à partir d'un compartiment interstitiel du patient à travers la peau du patient.